By Drug Target Review2025-07-03T13:30:31
Scientists at the University of Sydney have discovered a malfunctioning brain protein linked to Parkinson’s - which could lead to new therapies for the debilitating condition in the future.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-11T14:00:00
Sponsored by Merck
2023-09-06T16:55:04
Sponsored by NanoTemper Technologies
2024-05-10T11:23:31
Sponsored by BellBrook Labs
2024-02-07T14:34:33
Sponsored by BellBrook Labs
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2023-05-10T11:18:16
Sponsored by Revvity
Site powered by Webvision Cloud